AHR and Alzheimer disease: Another potential treatment target in managing AD is to modulate the skin microbiome, first, to prevent the Staphylococcus/Alternaria interaction and, second, to increase the abundance of beneficial microbiota that has been reported to play a significant role in regulating skin barrier formation and repair via aryl hydrocarbon receptor in keratinocytes (Uberoi et al., 2021).